Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery. Recently, a new robotic surgical system (Sentire Robotic Surgical System) was introduced by researchers of The Chinese University of Hong Kong (CUHK). This new robotic surgical system aims to achieve similar outcomes and standards of robotic surgery performed using the dominating system but with a significantly lower cost. The technologic innovation and development of this new robotic system is made by the Cornerstone Robotics Limited, which is based in Hong Kong. In a pilot clinical study conducted at Prince of Wales Hospital involving 55 patients, the Sentire Robotic Surgical System had demonstrated high success rate with minimal complications in patients who underwent robotic colorectal, upper gastrointestinal, and urologic surgery. Researchers of CUHK would therefore like to conduct another prospective study to further evaluate the efficacy and safety of Sentire Surgical System C1000 in major gastrointestinal and urologic surgery with expanded indications. It is believed that the results of this study will provide data to support its use for wide range of procedures with minimal access trauma, for the benefit of patients. This system will also lead to a wider range of clinical application for minimally invasive surgery with a cost-effective model.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Body mass index \<35 kg/m2

• Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases

• Willingness to participate as demonstrated by giving informed consent

⁃ \- Adenocarcinoma or large adenoma (not amenable to endoscopic removal) located at the colorectum (from the cecum to the anal verge) amenable to minimally invasive surgery

⁃ \- Mid/low rectal adenocarcinoma located \<12 cm from the anal verge

• Clinically diagnosed with previously untreated and uncomplicated rectal prolapse or enterocele

⁃ \- Clinically diagnosed with nonmetastatic adenocarcinoma of prostate

⁃ \- Clinically diagnosed with nonmetastatic kidney cancer

⁃ \- Clinically diagnosed with nonmetastatic bladder cancer

⁃ Robotic Esophageal Hiatal Surgery and Fundoplication

⁃ \- Clinically diagnosed with Hiatal Hernia and / or Gastroesophageal reflux disease amendable to fundoplication

⁃ \- Clinical diagnosis of gastric tumor (Adenocarcinoma or Gastrointestinal Stromal Tumor (GIST)) amendable to minimally invasive radical gastrectomy

⁃ \- Clinical diagnosis of carcinoma of esophagus amendable to minimally invasive esophagectomy

⁃ \- Symptomatic gallbladder stones clinically indicated for laparoscopic cholecystectomy

Locations
Other Locations
China
Prince of Wales Hospital, The Chinese University of Hong Kong
RECRUITING
Hong Kong
Contact Information
Primary
Simon SM Ng, MD
simonng@surgery.cuhk.edu.hk
+852-35051495
Time Frame
Start Date: 2025-03-25
Estimated Completion Date: 2027-04
Participants
Target number of participants: 90
Treatments
Experimental: Robotic surgery using the Sentire Surgical System
Robotic surgery using the Sentire Surgical System
Sponsors
Leads: Chinese University of Hong Kong

This content was sourced from clinicaltrials.gov